Glantreo, through its partners, has applied its technologies to addressing issues in the pharmaceutical and drug delivery space. Glantreo’s partners have come to value the synergy of adding their pharmaceutical or biopharmaceutical experience with Glantreo’s extensive material science experience (in particular mesoporous nano particles) along with a practical and rigorous methodology. Additionally, Glantreo has been deeply involved in EU Projects (and continues to engage with current consortium for Horizon 2020) where the synthesis, and characterisation/testing of these nanomaterials has been directly towards pharma and nanotoxicology applications. The following are some examples of pharmaceutical/biopharmaceutical areas that Glantreo have worked in: